Innovation
10 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 279 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Social engagement
Social engagement: 2.7K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include Oxford Science Enterprises, Braavos.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 4 | 50% |
Recent activity
7 Jan 2026
Event
J.P. Morgan Healthcare Conference 2026
10 Dec 2025
Partnership
Oxford Science Enterprises
3 Sep 2025
Event
Congenital Cytomegalovirus Public Health & Policy Conference